Trials / Withdrawn
WithdrawnNCT01827969
Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Institut Bergonié · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The treatment consists of tumor ablation by Ablathermy Focused Ultrasound (USF), guided by MRI, performed under local anesthesia and sedation.
Detailed description
The treatment consists of tumor ablation by USF, guided by MRI, performed under local anesthesia and sedation. Patients will be operated (mastectomy) from 48 hours after ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ablathermy focused ultrasound | ablathermy focused ultrasound |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2013-04-10
- Last updated
- 2025-09-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01827969. Inclusion in this directory is not an endorsement.